Iradimed (IRMD) Share-based Compensation (2013 - 2026)

Iradimed (IRMD) has 14 years of Share-based Compensation data on file, last reported at $684000.0 in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 489.66% year-over-year to $684000.0 in Q1 2026; TTM through Mar 2026 was $4.8 million, a 27.44% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 15.65% from the prior year.
• Share-based Compensation for Q1 2026 stood at $684000.0, down from $2.7 million in the prior quarter.
• Over the last five years, Share-based Compensation for IRMD reached as high as $2.7 million in Q4 2025 and fell as low as $49876.0 in Q1 2023.
• Historically, Share-based Compensation has averaged $801471.1 across 5 years, with a median of $609096.0 in 2024.
• Across the five-year window, Share-based Compensation plunged 89.0% in 2023 and surged 1160.41% in 2024, its largest moves.
• Year by year, Share-based Compensation stood at $426555.0 in 2022, then surged by 359.24% to $2.0 million in 2023, then gained by 21.41% to $2.4 million in 2024, then gained by 12.56% to $2.7 million in 2025, then sank by 74.45% to $684000.0 in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $684000.0 in Q1 2026, $2.7 million in Q4 2025, and $666083.0 in Q3 2025.